BCL-2 overexpression is found to be associated with different types of cancers such as prostate cancer, chronic lymphocytic leukemia, non-small cell lung cancer, breast cancer, esophageal cancer, lung cancer, and endometrial cancer [21–25]. Here, BCL2 is linked to B-cell chronic lymphocytic leukemia.